Shalby Limited (SHALBY)
Investor Presentation
AI summary
- Consolidated Q1 FY27 revenue at ₹3,386 mn, +11.6% y-y; EBITDA ₹490 mn, +0.9% y-y; PAT ₹105 mn, +36.7% y-y
- Standalone Q1 FY27 revenue ₹2,591 mn, +7.0% y-y; EBITDA ₹478 mn, -8.8% y-y; PAT ₹251 mn, -2.4% y-y
- Hospital business occupancy improved to 51% in Q1 FY27 from 45% y-y
- Shalby MedTech Q1 FY27 revenue ₹471.7 mn, +53% y-y; EBITDA marginally positive
- Expansion plans include Mumbai hospitals and focus on doubling ROCE in coming year
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 SHALBY — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add SHALBY to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Shalby Limited
Important.
The summary above is generated automatically from Shalby Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.